###begin article-title 0
The Macrophage Scavenger Receptor A Is Host-Protective in Experimental Meningococcal Septicaemia
###end article-title 0
###begin p 1
Conceived and designed the experiments: AP JCH ERM SG. Performed the experiments: AP JCH KM. Analyzed the data: AP JCH ERM SG. Contributed reagents/materials/analysis tools: ERM SG. Wrote the paper: AP JCH.
###end p 1
###begin p 2
###xml 75 97 75 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitidis</italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 262 269 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 305 320 305 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 418 421 418 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 453 468 453 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 809 812 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1290 1293 1290 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1719 1726 1719 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 75 97 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 305 320 <span type="species:ncbi:487">N. meningitidis</span>
###xml 345 351 <span type="species:ncbi:10090">murine</span>
###xml 453 468 <span type="species:ncbi:487">N. meningitidis</span>
###xml 1098 1102 <span type="species:ncbi:10090">mice</span>
Macrophage Scavenger Receptor A (SR-A) is a major non-opsonic receptor for Neisseria meningitidis on mononuclear phagocytes in vitro, and the surface proteins NMB0278, NMB0667, and NMB1220 have been identified as ligands for SR-A. In this study we ascertain the in vivo role of SR-A in the recognition of N. meningitidis MC58 (serogroup B) in a murine model of meningococcal septicaemia. We infected wild-type and SR-A-/- animals intraperitoneally with N. meningitidis MC58 and monitored their health over a period of 50 hours. We also determined the levels of bacteraemia in the blood and spleen, and measured levels of the pro-inflammatory cytokine interleukin-6 (IL-6). The health of SR-A-/- animals deteriorated more rapidly, and they showed a 33% reduction in survival compared to wild-type animals. SR-A-/- animals consistently exhibited higher levels of bacteraemia and increased levels of IL-6, compared to wild-type animals. Subsequently, we constructed a bacterial mutant (MC58-278-1220) lacking two of the SR-A ligands, NMB0278 and NMB1220. Mutation of NMB0667 proved to be lethal. When mice were infected with the mutant bacteria MC58-278-1220, no significant differences could be observed in the health, survival, bacteraemia, and cytokine production between wild-type and SR-A-/- animals. Overall, mutant bacteria appeared to cause less severe symptoms of septicaemia, and a competitive index assay showed that higher levels of wild-type bacteria were recovered when animals were infected with a 1:1 ratio of wild-type MC58 and mutant MC58-278-1220 bacteria. These data represent the first report of the protective role of SR-A, a macrophage-restricted, non-opsonic receptor, in meningococcal septicaemia in vivo, and the importance of the recognition of bacterial protein ligands, rather than lipopolysaccharide.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 255 277 255 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitidis</italic>
###xml 437 452 437 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 511 526 511 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 1208 1223 1208 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 255 277 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 437 452 <span type="species:ncbi:487">N. meningitidis</span>
###xml 458 463 <span type="species:ncbi:10090">mouse</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 511 526 <span type="species:ncbi:487">N. meningitidis</span>
###xml 543 548 <span type="species:ncbi:10090">mouse</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">Mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 1208 1223 <span type="species:ncbi:487">N. meningitidis</span>
Macrophages are innate immune cells that provide a first defence against infection. Several receptors on the surface of macrophages mediate recognition of invading pathogens, and one of these is the Macrophage Scavenger Receptor A (SR-A). SR-A recognises Neisseria meningitidis, a bacterium that causes meningitis and septic shock, via proteins on the surface of the bacterium. In this study we investigated the interaction of SR-A with N. meningitidis in a mouse model for septic shock, by infecting mice with N. meningitidis and comparing a mouse strain expressing SR-A with one that does not. The health of mice not expressing SR-A deteriorated more rapidly and fewer animals survived compared to those expressing SR-A. Mice lacking SR-A had higher numbers of bacteria in their blood and also produced more cytokines that can cause septic shock. We also infected mice with bacteria that did not express two of the proteins recognised by SR-A. In this case, no differences in survival, levels of bacteria, or cytokines were detected between animals that expressed SR-A and those that did not. Therefore, we show that the macrophage receptor SR-A is protective in the development of septic shock induced by N. meningitidis.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 485 488 483 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Plddemann1">[1]</xref>
###xml 645 648 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Krieger1">[2]</xref>
###xml 980 983 974 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Hughes1">[3]</xref>
###xml 1042 1045 1036 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Brown1">[4]</xref>
###xml 1134 1137 1128 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Becker1">[5]</xref>
###xml 1239 1242 1233 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Naito1">[6]</xref>
The innate immune system is a first line of defence against invading pathogens and macrophages play an integral role in the innate immune defence against bacterial infection. This is based on the recognition of conserved microbial structures, termed pathogen-associated molecular patterns (PAMPs), by a range of pattern recognition receptors (PRRs). Macrophages (Mphi) express different classes of innate PRRs with diverse functions, including the phagocytic Scavenger receptors (SRs) [1]. One of the receptors belonging to this family is the class A scavenger receptor (SR-A), which has been shown to recognise a range of polyanionic molecules [2]. SR-A is a trimeric type II transmembrane glycoprotein consisting of a cytoplasmic tail, transmembrane domain, spacer region, alpha-helical coiled coil domain, collagenous domain and C-terminal cysteine-rich domain. SR-A expression is mostly restricted to macrophages and is not found on polymorphonuclear neutrophils or monocytes [3]. Recently, the expression of SR-A was shown on mast cells [4] and specific sub-populations of bone marrow-derived dendritic cells (DC) and splenic DC [5]. Selected endothelial cells and smooth muscle cells within atherosclerotic plaques also express SR-A [6].
###end p 6
###begin p 7
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Peiser1">[7]</xref>
###xml 369 372 369 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Hampton1">[8]</xref>
###xml 488 491 488 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Greenberg1">[9]</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Zhu1">[10]</xref>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Dunne1">[11]</xref>
###xml 1033 1040 1033 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1104 1107 1104 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1152 1155 1152 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1248 1270 1248 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 1281 1285 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Suzuki1">[12]</xref>
###xml 1291 1294 1291 1294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1340 1361 1340 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 1366 1390 1366 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 1401 1405 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Thomas1">[13]</xref>
###xml 1406 1410 1406 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Arredouani1">[14]</xref>
###xml 1524 1527 1524 1527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1611 1615 1611 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Haworth1">[15]</xref>
###xml 1972 1976 1972 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Cotena1">[16]</xref>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
###xml 1248 1270 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 1295 1299 <span type="species:ncbi:10090">mice</span>
###xml 1340 1361 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 1366 1390 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 1528 1532 <span type="species:ncbi:10090">mice</span>
The Scavenger receptors play an important role in microbial recognition and clearance, and SR-A has been shown to bind both Gram-positive and Gram-negative bacteria [7]. Hampton and colleagues first proposed that SR-A might be involved in antimicrobial host defence, based on their observation that SR-A could bind lipid A, an integral part of lipopolysaccharide (LPS) [8]. Subsequent studies showed that SR-A also recognises the Gram-positive cell-wall component lipoteichoic acid (LTA) [9]. Furthermore, SR-A binds to different LTA structures with varying specificity depending on their exposed negative surface charge. Unmethylated bacterial CpG DNA, another major immunostimulatory microbial product, is also recognised by SR-A [10]. Using a range of Gram-positive organisms, Dunne and co-workers confirmed that both soluble and cell-associated forms of SR-A are not only able to bind bacterial components, but can also recognise intact live organisms [11]. SR-A has been shown to play a role in both infection and inflammation. In vivo studies with three Gram-positive organisms have shown that SR-A-/- mice are more susceptible to infection. SR-A-/- animals exhibited deficient clearance of bacteria from the liver and spleen in experimental Listeria monocytogenes infection [12]. SR-A-/- mice also showed increased susceptibility to Staphylococcus aureus and Streptococcus pneumoniae infection [13],[14]. A possible anti-inflammatory host-protective role of SR-A was proposed by Haworth et al., who observed that SR-A-/- mice formed normal granulomas in response to BCG (Bacille Calmette-Guerin) priming [15]. However, these animals were more susceptible to endotoxic shock as a result of increased pro-inflammatory cytokine secretion in response to additional lipopolysaccharide (LPS) challenge. In addition, SR-A has been shown to modulate chemokine levels in specific acute inflammatory conditions to ensure an inflammatory response of the appropriate magnitude [16].
###end p 7
###begin p 8
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitidis</italic>
###xml 288 303 288 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Peiser2">[17]</xref>
###xml 405 425 405 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis lpxA</italic>
###xml 462 477 462 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Peiser3">[18]</xref>
###xml 669 676 669 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 929 936 929 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1018 1033 1018 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 0 22 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 224 232 <span type="species:ncbi:9606">children</span>
###xml 288 303 <span type="species:ncbi:487">N. meningitidis</span>
###xml 405 420 <span type="species:ncbi:487">N. meningitidis</span>
###xml 462 477 <span type="species:ncbi:487">N. meningitidis</span>
###xml 711 717 <span type="species:ncbi:10090">murine</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1018 1033 <span type="species:ncbi:487">N. meningitidis</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
Neisseria meningitidis is a Gram-negative obligate commensal bacterium that colonises the human nasopharynx, however when the bacterium crosses this barrier, it causes meningitis and rapid septicaemia, particularly in young children and teenagers. We have shown previously that uptake of N. meningitidis by macrophages is mediated almost exclusively via SR-A [17]. Interestingly, experiments employing an N. meningitidis lpxA mutant revealed that recognition of N. meningitidis by SR-A was independent of lipopolysaccharide, and we identified three bacterial surface protein ligands for SR-A, namely NMB0278, NMB0667 and NMB1220 [18]. In this study we investigated the in vivo role of SR-A in inflammation in a murine meningococcal septicaemia model. We also ascertained the contribution of the identified surface protein ligands by constructing bacterial mutants in the SR-A ligands and examining the effects of a double mutant in vivo. We show that SR-A knock-out mice are more susceptible to septicaemia induced by N. meningitidis than wild-type mice, and that for double knock-out bacteria lacking two SR-A ligands, these effects are abrogated.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
Chemicals and Reagents
###end title 10
###begin p 11
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Hirsch1">[19]</xref>
###xml 365 368 <span type="species:ncbi:10116">rat</span>
###xml 468 471 <span type="species:ncbi:10116">rat</span>
###xml 508 514 <span type="species:ncbi:10090">murine</span>
###xml 589 592 <span type="species:ncbi:10116">rat</span>
###xml 625 631 <span type="species:ncbi:10090">murine</span>
Unless otherwise stated, all chemicals were from Sigma (Poole, United Kingdom). Acetylated low density lipoprotein (AcLDL) and Rhodamine Green X (RdGnX) were obtained from Molecular Probes (Eugene, OR, USA). The TMB substrate reagent set was purchased from BD Biosciences Pharmingen (San Diego, CA). All culture media were from Gibco (Paisley, United Kingdom). The rat monoclonal anti-CD68 monoclonal antibody FA-11 was obtained from AbD Serotec (Kidlington, UK). The rat monoclonal antibody against the 7/4 murine differentiation antigen was generated in this laboratory [19]. M5114, the rat monoclonal antibody recognising murine MHC-II was obtained from R&D Systems (Abingdon, UK).
###end p 11
###begin title 12
Bacterial Strains and Culture Conditions
###end title 12
###begin p 13
###xml 4 26 4 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitidis</italic>
###xml 68 75 68 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000297-t001">Table 1</xref>
###xml 303 304 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 380 382 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 412 414 398 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 449 465 435 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 629 631 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 661 663 629 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 692 694 656 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 742 757 706 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 4 26 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 449 465 <span type="species:ncbi:562">Escherichia coli</span>
###xml 742 757 <span type="species:ncbi:487">N. meningitidis</span>
The Neisseria meningitidis strains used in this study are listed in Table 1. All strains were grown overnight at 37degreesC on brain-heart infusion (BHI) medium (Oxoid), supplemented with Levinthal's reagent (10% vol/vol) and solidified with agar (1% [wt/vol]; Bioconnections), in an atmosphere of 5% CO2. For selection of strains following transformation, kanamycin (75 microg ml-1) or erythromycin (6 microg ml-1) was added to the culture medium. Escherichia coli strain DH5alpha was used to propagate recombinant DNA constructs and was grown at 37degreesC on Luria-Bertani (LB) medium supplemented with kanamycin (50 microg ml-1), erythromycin (300 microg ml-1) or ampicillin (50 microg ml-1) where appropriate. For fluorescent labelling, N. meningitidis were fixed with 70% ethanol and labelled with RdGnX according to the manufacturer's instructions.
###end p 13
###begin title 14
###xml 8 23 8 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 8 23 <span type="species:ncbi:487">N. meningitidis</span>
List of N. meningitidis strains and plasmids used in this study.
###end title 14
###begin title 15
DNA Techniques
###end title 15
###begin p 16
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Sambrook1">[20]</xref>
###xml 476 477 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 559 562 547 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 933 948 897 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 981 985 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Ausubel1">[21]</xref>
###xml 1052 1059 1016 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000297-t002">Table 2</xref>
###xml 933 948 <span type="species:ncbi:487">N. meningitidis</span>
Recombinant DNA techniques were performed as described by Sambrook et al.[20]. Restriction endonuclease and DNA modifying enzymes were obtained from Boehringer Mannheim or New England Biolabs and used according to the manufacturers' instructions. Oligonucleotide primers were synthesised by Sigma-Genosys. Standard polymerase chain reaction (PCR) amplifications were performed in 50 microl reaction volumes (final concentrations: 20 mM Tris-HCl, pH 8.4; 50 mM KCl; 2.5 mM MgCl2; 0.4 microM forward primer; 0.4 microM reverse primer; 0.4 mM dNTPs) with 1.25 U Taq recombinant polymerase (Invitrogen, Paisley, UK) in a Master-Cycler (Eppendorf) gradient thermal cycler. Thirty cycles of PCR were performed, each consisting of 1 min denaturation at 94degreesC, 1 min annealing at typically 5degreesC below Tm and 1 min extension at 72degreesC, with a final prolonged extension of 10 min at 72degreesC. Chromosomal DNA was prepared from N. meningitidis strains as described previously [21]. A list of oligonucleotide primers used in this study is given in Table 2.
###end p 16
###begin title 17
List of oligonucleotide primers used in this study.
###end title 17
###begin title 18
Tricine-SDS-PAGE
###end title 18
###begin p 19
###xml 43 58 43 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Williams1">[22]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Heckels1">[23]</xref>
###xml 559 560 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 758 759 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 824 839 804 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 1293 1297 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Lesse1">[24]</xref>
###xml 43 58 <span type="species:ncbi:487">N. meningitidis</span>
###xml 824 839 <span type="species:ncbi:487">N. meningitidis</span>
Outer membrane vesicles were prepared from N. meningitidis cells as described by Heckels and Williams et al [22],[23]. Briefly, cells were harvested from confluent growth of bacteria on 40 BHI plates into 0.2 M lithium acetate (40 ml, pH 5.8) and extracted at 45degreesC in the presence of 2 mm glass beads (20 ml). Live bacteria were removed by centrifugation at 13,00 g, 20 min, the supernatant was then subjected to a repeat of this step. The outer membranes were recovered by centrifugation at 11,000 g, 4degreesC, 2 h and the resuspended in 200 microl dH2O. The protein concentration of the outer membranes was determined by performing a Lowry MicroAssay (Sigma) according to the manufacturer's instructions. 15 microg of total protein was diluted in dH2O and loaded in each well. Whole cell lysates were prepared from N. meningitidis strains grown overnight, by harvesting and resuspending cells in PBS and then adding the equivalent amount of dissociation buffer (125 mM Tris, pH 6.8, 20% [v/v] glycerol, 3.9% [w/v] SDS, 10% beta-mercaptoethanol, 0.04% [w/v] bromphenol blue). All samples were boiled at 100degreesC for 5 min. Samples were separated by tricine-sodium dodecyl sulphate-polyacrylamide gel electrophoresis (T-SDS-PAGE) using 16.5% gels run at 30 mA at 4degreesC for 18 hr [24], and were visualised by staining with silver nitrate according to the manufacturer's instructions (Amersham Biosciences).
###end p 19
###begin title 20
Disruption of Genes and Construction of Mutant Strains
###end title 20
###begin p 21
###xml 14 29 14 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kan<sup>R</sup></italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinc</italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinc</italic>
###xml 418 433 418 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Wright1">[25]</xref>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kanR</italic>
###xml 14 29 <span type="species:ncbi:487">N. meningitidis</span>
###xml 418 433 <span type="species:ncbi:487">N. meningitidis</span>
To mutate the N. meningitidis NMB0278 gene, the gene was first amplified by PCR from strain H44/76 chromosomal DNA with oligonucleotide primers 278-f/278-r and cloned into the plasmid pT7Blue (Novagen). A kanamycin resistance (kanR) cassette was excised from pUC4-kan by digestion with HincII and inserted into the HincII site within the cloned NMB0278 gene. The resulting construct, pT7-278-kan was used to transform N. meningitidis strain MC58 as described previously [25]. Screening of transformants was performed by PCR using primers designed to bind within the kanR cassette and in the neighbouring gene to identify transformants containing a single, disrupted copy of NMB0278.
###end p 21
###begin p 22
###xml 14 29 14 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ermC</italic>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Jennings1">[26]</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinc</italic>
###xml 321 324 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sma</italic>
###xml 423 438 423 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ermC</italic>
###xml 14 29 <span type="species:ncbi:487">N. meningitidis</span>
###xml 423 438 <span type="species:ncbi:487">N. meningitidis</span>
To mutate the N. meningitidis NMB0667 gene, the gene was first amplified by PCR from strain H44/76 chromosomal DNA with oligonucleotide primers 667-f/667-r and cloned into the plasmid pT7Blue (Novagen). An erythromycin resistance cassette (ermC) was excised from pER2 [26], by digestion with HincII and inserted into the SmaI site within the cloned NMB0667 gene. The resulting construct, pT7-667-ery, was used to transform N. meningitidis strain MC58. Transformants were screened by PCR using primers designed to bind within the ermC cassette and in the neighbouring gene to identify a transformant containing a single, disrupted copy of NMB0667.
###end p 22
###begin p 23
###xml 95 110 95 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ermC</italic>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Jennings1">[26]</xref>
###xml 441 444 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eag</italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eag</italic>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ermC</italic>
###xml 679 682 679 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 815 830 815 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 95 110 <span type="species:ncbi:487">N. meningitidis</span>
###xml 815 830 <span type="species:ncbi:487">N. meningitidis</span>
To mutate the gene NMB1220, the 5' and 3' regions of the gene were first amplified by PCR from N. meningitidis strain MC58 chromosomal DNA, with oligonucleotide primers 1220-3f/1220-3r and 1220-5f/1220-5r, respectively, before cloning each product separately into pT7Blue, resulting in the plasmids pT7-1220-3 and pT7-1220-5. The ermC cassette was amplified from pER2 [26] with oligonucleotide primers ery-eag-f and ery-eag-r, digested with EagI and inserted into the EagI site present within the cloned 3' region of the NMB1220 gene in pT7-1220-3 to give the construct pT7-1220-3-ery. The cloned 3' region of NMB1220, interrupted with ermC, was excised from pT7-1220-3-ery with XbaI and BglII and inserted into the corresponding site within pT7-1220-5. The resulting construct, pT7-1220-ery, was used to transform N. meningitidis strain MC58. Transformants were screened by PCR using oligonucleotide primers 1220-f/1220-r designed to bind within NMB1220 to identify a transformant containing a single, disrupted copy of NMB1220.
###end p 23
###begin title 24
###xml 42 47 <span type="species:ncbi:9606">Human</span>
Resistance to the Bactericidal Effects of Human Sera
###end title 24
###begin p 25
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Hood1">[27]</xref>
###xml 55 60 <span type="species:ncbi:9606">human</span>
Bacteria cultured on BHI plates were assayed in pooled human serum as described previously [27].
###end p 25
###begin title 26
Cell Culture
###end title 26
###begin p 27
###xml 79 82 77 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Peiser1">[7]</xref>
###xml 226 230 <span type="species:ncbi:9913">calf</span>
Bone marrow-derived macrophages (BMMphi) were prepared as described previously [7]. Mphi were routinely cultured in RPMI supplemented with 100 U/ml penicillin, 100 microg/ml streptomycin and 2 mM L-glutamine (PSG), 10% foetal calf serum (FCS) and 15% L-cell conditioned medium.
###end p 27
###begin title 28
Uptake Assays
###end title 28
###begin p 29
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Bone marrow-derived macrophages were plated in 6-well bacteriological plastic dishes at a density of 1x106 Mphi per well 24 hours before use. Mphi were washed twice in PBS and then incubated in Opti-MEM medium (Invitrogen, Paisley, UK) containing fluorescently-labelled bacteria as specified. After incubation with bacteria, the culture medium was removed and the cells washed three times with PBS. Cells for flow cytometry were harvested with PBS containing 10 mM EDTA and 4 mg/ml lidocaine-HCl and fixed with 4% (v/v) formaldehyde in PBS. Fluorescence was analysed on a FACScan (Becton Dickinson, Mountain View, CA) using the FL-1 or FL-2 photomultiplier where appropriate and the results analysed with CellQuest software. Results are representative of at least 3 independent experiments.
###end p 29
###begin title 30
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Infection Studies
###end title 30
###begin p 31
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Gorringe1">[28]</xref>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Suzuki1">[12]</xref>
###xml 2 8 <span type="species:ncbi:10090">murine</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
A murine intraperitoneal challenge model for bacterial clearance was employed [28]. C57BL/6J wild-type mice and a corresponding SR-A-/- knock-out mouse strain were used. SR-A-/- animals were developed and bred onto C57BL/6J background using standard molecular biology techniques [12]. All animals were bred and housed under specific pathogen-free conditions.
###end p 31
###begin p 32
###xml 65 66 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 224 225 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 282 285 276 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">620</sub>
###xml 395 396 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 470 473 446 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">620</sub>
Meningococcal strains were grown overnight at 37degreesC in 5% CO2 on BHI plates as described above. Muller Hinton broth (8 ml) supplemented with 0.25% (w/v) glucose in a 50 ml tissue culture flask was inoculated with 1.2x109 cfu from the overnight growth resulting in an initial OD620 of approximately0.1. The flask was incubated horizontally on a gently rocking platform at 37degreesC in 5% CO2 and bacteria were cultured to mid-logarithmic growth phase, defined as OD620 of approximately0.5 (approximately 2.5 h). The bacteria were transferred to 1.5 ml tubes and harvested by centrifugation at 1900 g for 5 min and then resuspended in PBS. The bacterial suspensions were adjusted to the required concentration for inoculation in BHI broth.
###end p 32
###begin p 33
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 222 225 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 896 900 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Newcombe1">[29]</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 507 512 <span type="species:ncbi:10090">mouse</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
Bacterial doses of 1x105 cfu/mouse were injected intraperitoneally (i.p.) with human holo-transferrin (Sigma, 10 mg/mouse) in a total volume of 500 microl to groups of 6-8-week-old wild-type C57BL/6J and corresponding SR-A-/- knock-out inbred female mice. At the time of infection, the actual dose delivered to each group of mice was determined by serial dilution and replicate colony plating. At 18 h after the initial infection, mice were boosted i.p. with a further dose of human holo-transferrin (10 mg/mouse in 200 microl PBS). The health of the animals was monitored and scored at regular time points according to the symptoms presented as follows: Healthy = 5, ruffled fur = 4, sticky eyes = 3, ruffled fur and sticky eyes = 2, immobile = 1. As soon as immobile mice were detected they were humanely killed. Scores were then collated and averaged for each group at the various time points [29]; (A. Gorringe, personal communication). Survival curves were also plotted and statistical significance determined using the Log-rank (Mantel Cox) test. Blood samples from the tail vein (5 microl) were taken at 20 h post-infection and serial dilutions plated to determine bacteraemia. All dilutions were made with PBS. At termination, blood was collected by cardiac puncture and spleens removed. Half of each spleen was fixed in 2% paraformaldehyde in HEPES-buffered isotonic saline for immunohistochemical analysis. The remaining spleen was homogenized and serial dilutions of spleen and blood were plated to determine bacteraemia. The remaining blood was separated by centrifugation and the plasma collected and frozen at -80degreesC for later use. All procedures involving animals were conducted according to the requirements of the United Kingdom Home Office Animals (Scientific Procedures) Acts, 1986.
###end p 33
###begin title 34
Immunohistochemistry
###end title 34
###begin p 35
###xml 598 604 <span type="species:ncbi:9986">rabbit</span>
Fixed tissues were transferred to a solution of 0.1 M sodium phosphate buffer containing 20% sucrose, placed in Tissue-Tek OCT compound (VWR International Ltd., Lutterworth, UK) and snap-frozen in isopentane cooled by dry ice. Frozen sections were cut on a Leica cryostat (5 microm thick), collected onto 1.5% gelatinized slides, air dried for 1 hour and stored at -20degreesC. Sections were washed in 0.1% Triton X-100 and endogenous peroxidase activity was quenched by incubation in PBS containing 0.01 M glucose, 0.001 M sodium azide and 40 U glucose oxidase for 15 min at 37degreesC. 5% Normal rabbit serum was used as blocking agent for non-specific binding and avidin/biotin blocking agents (Vector Laboratories Ltd., Peterborough, UK) were employed according to the manufacturer's instructions. Sections were incubated for 60 min in the respective primary antibodies or isotype-matched controls, washed and incubated for 30 min with the respective affinity purified biotinylated secondary antibodies. Finally, sections were washed and incubated with the avidin-biotin peroxidase complex (ABC elite, Vector Laboratories Ltd., Peterborough, UK) for 30 min and staining visualised by incubation with 0.5 mg/ml diaminobenzidine (Polysciences Inc., Northampton, UK) and hydrogen peroxide in 10 mM imidazole. Sections were counterstained with 0.1% methyl green (Vector Laboratories Ltd. Peterborough, UK) and mounted in DPX (VWR International Ltd., Lutterworth, UK).
###end p 35
###begin title 36
Cytokine Analysis
###end title 36
###begin p 37
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 104 109 <span type="species:ncbi:10090">Mouse</span>
The concentration of interleukin-6 (IL-6) in the plasma of infected mice was determined using an OptEIA Mouse IL-6 ELISA set (BD Biosciences, San Diego) according to the manufacturer's instructions.
###end p 37
###begin title 38
Competitive Index Assay
###end title 38
###begin p 39
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 112 127 112 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 150 165 150 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 211 216 <span type="species:ncbi:9606">human</span>
###xml 565 570 <span type="species:ncbi:9606">human</span>
Groups of five 6-8-week-old female wild-type C57BL/6J and corresponding SR-A-/- animals were infected with 1x106N. meningitidis MC58 (wild-type)+1x106N. meningitidis MC58-278-1220 (mutant) i.p, along with 10 mg human holo-transferrin. The two bacterial strains were individually grown overnight as before. Serial dilutions of the inoculum were also plated onto both BHI medium and BHI medium supplemented with kanamycin (which selects for MC58-278-1220 mutant bacteria), in order to verify the dose and ratio of wild-type to mutant bacteria. A second dose of 10 mg human holo-transferrin was injected i.p. at 18 h. The health of the animals was monitored as before. At termination, blood was collected by cardiac puncture and spleens removed. Spleens were homogenized and serial dilutions of blood and spleen samples were plated on BHI medium and BHI medium supplemented with kanamycin. Enumeration of wild-type bacteria and mutant bacteria allowed for the determination of the CI ratio between wild-type and mutant bacteria using the following formula: CI = (wild-type output/mutant output)/(wild-type input/mutant input). The statistical significance of the results was determined using the paired student's t-test.
###end p 39
###begin title 40
Results
###end title 40
###begin title 41
###xml 28 43 28 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 28 43 <span type="species:ncbi:487">N. meningitidis</span>
Construction and Evaluation N. meningitidis Mutant Strains
###end title 41
###begin p 42
###xml 81 96 81 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 810 825 810 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 81 96 <span type="species:ncbi:487">N. meningitidis</span>
###xml 810 825 <span type="species:ncbi:487">N. meningitidis</span>
To investigate the importance of NMB0278, NMB0667 and NMB1220 for recognition of N. meningitidis by SR-A, plasmids were constructed containing each gene interrupted by insertion of a kanamycin or erythromycin resistance cassette. The constructs pT7-278-kan and pT7-667-ery resulted from a single PCR product from NMB0278 and NMB0667, respectively, cloned into pT7Blue and then interrupted with an antibiotic resistance cassette. It is interesting to note that when a similar approach was utilised with NMB1220, the initial pT7-1220 construct proved to be highly unstable and consequently a two step approach of cloning the 5' and 3' regions of the gene together with some flanking DNA was undertaken, which proved to be successful. The plasmids pT7-278-kan, pT7-667-ery and pT7-12220-ery were transformed into N. meningitidis strain MC58.
###end p 42
###begin p 43
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kanR</italic>
The serogroup B genome sequence contains two homologues of NMB0278, namely NMB0294 and NMB0407. To ensure that only NMB0278 had been disrupted, specific oligonucleotide primers were designed to bind within the kanR cassette and in the neighbouring gene to identify transformants containing a single, disrupted copy of NMB0278. This transformant was designated MC58-278.
###end p 43
###begin p 44
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ermC</italic>
The gene NMB0667 shows low levels of homology to a degenerate DNA methylase found elsewhere in the serogroup B genome (NMB1223), so primers designed to bind within the ermC cassette and in the neighbouring gene were utilised to identify transformants containing a single, disrupted copy of NMB0667. A number of transformants were screened using different combinations of oligonucleotide primers. For each transformant containing an interrupted copy of NMB0667, an intact copy of the gene was present in tandem, therefore we concluded that NMB0667 is an essential gene, and consequently we were unable to obtain a mutant neisserial strain deficient in this protein.
###end p 44
###begin p 45
Double mutants where both NMB1220 and NMB0278 had been interrupted were constructed by transforming MC58-1220 with chromosomal DNA from MC58-278. The disruption of NMB0278 and NMB1220 was confirmed by the use of specific oligonucleotide primers as for the single mutants. This transformant was designated MC58-278-1220.
###end p 45
###begin title 46
Characterisation of NMB Mutants
###end title 46
###begin p 47
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 310 313 310 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">620</sub>
###xml 339 348 339 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g001">Figure 1A</xref>
###xml 574 583 574 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g001">Figure 1B</xref>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
The growth of the MC58-278, MC58-1220 and MC58-278-1220 in vitro was compared to that of the parental strain MC58. The bacteria were grown in Muller-Hinton broth in the same manner as for the preparation of inoculum for the mouse infection studies, except that growth was followed over an 8 h period and the OD620 was measured throughout (Figure 1A). All mutants exhibited growth curve patterns indistinguishable from the parent strain. Outer membranes were prepared from the mutants and parental strain following growth on BHI plates overnight and separated by T-SDS-PAGE (Figure 1B). The resulting profiles show that no significant differences were observed in the protein and LPS profiles. A comparison of the parental strain MC58 and the mutant strains showed no difference in the killing effect in pooled normal human serum (data not shown).
###end p 47
###begin title 48
###xml 36 51 36 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 36 51 <span type="species:ncbi:487">N. meningitidis</span>
Growth characteristics of wild-type N. meningitidis MC58 bacteria and mutant bacteria.
###end title 48
###begin p 49
###xml 4 19 4 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 204 207 204 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">620</sub>
###xml 4 19 <span type="species:ncbi:487">N. meningitidis</span>
(A) N. meningitidis strains MC58, MC58-278, MC58-1220, and MC58-278-1220 bacteria were grown in Muller-Hinton broth supplemented with 0.25% (w/v) glucose. Growth was followed over an 8-h period and the OD620 was measured throughout. (B) Outer membranes were prepared from the parental strain and mutants following growth on BHI plates overnight, and separated by T-SDS-PAGE. Lane order: 1, strain MC58; 2, strain MC58-278; 3, strain MC58-1220; 4, strain MC58-278-1220; 5, whole cell lysate strain MC58.
###end p 49
###begin title 50
###xml 63 78 63 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 63 78 <span type="species:ncbi:487">N. meningitidis</span>
Distribution of NMB0278, NMB0667, and NMB1220 across Different N. meningitidis Strains
###end title 50
###begin p 51
###xml 673 680 673 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000297-t003">Table 3</xref>
###xml 846 860 846 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. gonorrhoeae</italic>
###xml 959 968 959 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria</italic>
###xml 846 860 <span type="species:ncbi:485">N. gonorrhoeae</span>
In order to determine the distribution of these genes, a PCR screen was undertaken using primers specific not just for the gene under consideration, but also for its genomic location due to the homologous reading frames present for NMB0278 and NMB0667. 107 strains were screened using the following sets of primers; 278-out-f/278-out-r, 667-f/667-r, 667-f2/667-r and 1220-f/1220-r. This collection of strains was highly diverse and included representatives of disease and carriage isolates, along with well characterised reference strains. With the exception of one invasive disease strain, all gave a PCR product of the expected size for each of the three genes (refer to Table 3). The one anomalous strain demonstrated a PCR product for NMB0667 and NMB1220 but not for NMB0278. All three genes were determined to be present by this method in 7 N. gonorrhoeae isolates, however the distribution was found to vary considerably when other commensal species of Neisseria were analysed (data not shown).
###end p 51
###begin title 52
###xml 13 28 13 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 13 28 <span type="species:ncbi:487">N. meningitidis</span>
Screening of N. meningitidis strains for the presence of NMB0278, NMB0667, and MNB1220.
###end title 52
###begin p 53
LPS immunotyping reference strains.
###end p 53
###begin p 54
Genome sequenced serogroup A, B, and C strains.
###end p 54
###begin p 55
A highly diverse collection of strains representative of disease and carriage isolates and including well-characterised reference strains were screened by PCR using specific oligonucleotide primers for the presence or absence of each of the three genes.
###end p 55
###begin title 56
###xml 10 25 10 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 10 25 <span type="species:ncbi:487">N. meningitidis</span>
Uptake of N. meningitidis Mutant Strains by Bone Marrow-Derived Macrophages
###end title 56
###begin p 57
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 236 251 230 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 404 412 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g002">Figure 2</xref>
###xml 819 834 813 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 834 838 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Peiser3">[18]</xref>
###xml 236 251 <span type="species:ncbi:487">N. meningitidis</span>
###xml 819 834 <span type="species:ncbi:487">N. meningitidis</span>
To ascertain the in vitro macrophage uptake of wild-type bacteria compared to that of mutant bacteria, wild-type and SR-A-/- bone marrow-derived macrophages were incubated at 37degreesC for 2 h with ethanol-fixed fluorescently labelled N. meningitidis MC58 or the mutant bacteria with deletions in either NMB0278, NMB1220 or both (MC58-278, MC58-1220 and MC58-278-1220), respectively, at an MOI of 20:1 (Figure 2). Association of bacteria with macrophages was measured by flow cytometry. All the bacterial strains were taken up by wild-type macrophages, whereas uptake was reduced by at least 70% in macrophages lacking SR-A. However, no differences could be detected in the association of the mutant bacteria with wild-type macrophages. This could be attributed to the fact that there are multiple ligands for SR-A on N. meningitidis[18] and that the gene encoding at least one known ligand, NMB0667, could not be deleted. In addition, the strains still contained homologues for NMB0278.
###end p 57
###begin title 58
###xml 20 35 20 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 20 35 <span type="species:ncbi:487">N. meningitidis</span>
###xml 166 172 <span type="species:ncbi:10090">murine</span>
Uptake of wild-type N. meningitidis MC58 bacteria and mutant bacteria lacking NMB0278 (MC58-278), NMB1220 (MC58-1220), or both NMB0278 and NMB1220 (MC58-278-1220) by murine C57BL/6J wild-type (filled bars) and corresponding SR-A-/- knock-out (open bars) bone marrow-derived macrophages.
###end title 58
###begin p 59
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Macrophages were seeded on 6-well bacteriological plastic plates at 1x106 cells/well and incubated with RdGnX-labelled ethanol-fixed MC58 or mutants lacking the surface proteins at an MOI of 20:1 for 2 h at 37degreesC in the absence of serum. The Mphi were washed to remove extracellular bacteria, detached using lidocaine/EDTA, and fixed with 4% formaldehyde before analysis by flow cytometry. Each measurement was performed in triplicate, and results are representative of at least three similar assays. The error bars represent standard deviation. Differences are statistically significant and *** indicates p<0.001.
###end p 59
###begin title 60
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 54 58 <span type="species:ncbi:10090">Mice</span>
Meningococcal Septicaemia in Wild-Type versus SR-A-/- Mice
###end title 60
###begin p 61
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 216 231 216 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 651 654 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 698 699 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 699 714 699 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 791 806 791 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Holbein1">[30]</xref>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Letendre1">[31]</xref>
###xml 1308 1329 1308 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 1437 1446 1437 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g003">Figure 3A</xref>
###xml 139 145 <span type="species:ncbi:10090">murine</span>
###xml 216 231 <span type="species:ncbi:487">N. meningitidis</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 724 729 <span type="species:ncbi:10090">mouse</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 791 806 <span type="species:ncbi:487">N. meningitidis</span>
###xml 869 875 <span type="species:ncbi:10090">murine</span>
###xml 916 921 <span type="species:ncbi:9606">human</span>
Since no differences could be detected between wild-type and mutant bacteria in their interaction with SR-A in vitro, we set up an in vivo murine septicaemia model to investigate the role of SR-A in the clearance of N. meningitidis. First, we tested several bacterial doses in wild-type and SR-A-/- animals to determine the intraperitoneal (i.p.) dose required to establish bacteraemia in the blood and spleen, without causing rapid death of the animals, so that they could be monitored over time. From these experiments we selected a dose of 1x105 cfu/mouse (data not shown). Groups of six age-matched female C57BL/6J wild-type and corresponding SR-A-/- knock-out mice were injected i.p. with 1x105N. meningitidis MC58 cfu/mouse and 10 mg human holo-transferrin as a bacterial iron source. N. meningitidis requires iron for growth and is unable to sequester iron from murine transferrin [30],[31]. A second dose of human holo-transferrin was administered i.p. at 18 h to maintain available iron levels in the blood. Animals were monitored regularly over a period of 48 h for symptoms of septicaemia. Each individual was assigned a health score at each time point, according to the severity of symptoms (animals with a score of 5 were healthy, and a score of 1 was assigned when they were immobile, refer to materials and methods). Scores were then collated and averaged for the group, and the results plotted to provide a health curve (Figure 3A).
###end p 61
###begin title 62
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 116 131 116 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 147 152 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
Six 6-8-week-old female C57BL/6J wild-type and corresponding SR-A-/- mice were injected intraperitoneally with 1x105N. meningitidis MC58 and 10 mg human holo-transferrin per mouse.
###end title 62
###begin p 63
###xml 810 811 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 46 51 <span type="species:ncbi:9606">human</span>
At 18-h post-injection a second dose of 10 mg human holo-transferrin was administered i.p. (A) The health of the animals was monitored regularly and scored at each time point according to the symptoms presented as follows: Healthy = 5, ruffled fur = 4, sticky eyes = 3, ruffled fur and sticky eyes = 2, immobile = 1. Scores were then collated for each group at each time point, averaged and plotted. (B) The survival of each group was plotted, and the statistical curve comparison was determined using the Log-rank (Mantel Cox) test (P = 0.0305). (C) Blood was collected from the tail vein at 20 h and by cardiac puncture at termination (48 h), and serial dilutions were plated on bacterial growth medium. Spleen segments were also collected, homogenized, and plated. Plates were incubated at 37degreesC, 5% CO2 overnight, and bacterial colonies counted. Counts for six individual animals in each group are plotted. Results were analysed using a two-tailed, unpaired t test, and the star indicates a statistically significant difference (P<0.05). (D) The concentration of interleukin-6 in the plasma from infected animals was measured at termination (48 h) using a standard ELISA assay. Individual measurements from 6 animals in each group are plotted. Results were analysed using a two-tailed, unpaired t test, and the star indicates a statistically significant difference (P<0.05).
###end p 63
###begin p 64
###xml 216 225 216 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g003">Figure 3B</xref>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 383 386 383 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 652 661 652 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g003">Figure 3C</xref>
###xml 754 757 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 950 953 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Although animals in both groups exhibited symptoms of septicaemia, wild-type animals remained healthier, particularly after the second injection of iron, which would support bacterial proliferation. Survival curves (Figure 3B) also show that all the SR-A-/- animals had died at 32 h, while 33% of the wild-type animals survived beyond 48 h and recovered to full health. Overall, SR-A-/- animals showed more rapid deterioration of health and died more quickly than did wild-type animals. This could be correlated with the observation that SR-A-/- animals had higher levels of bacteraemia in their blood at both 20 h and 48 h than did wild-type animals (Figure 3C). Although there seemed to be a trend towards higher bacterial levels in the spleens of SR-A-/- animals, the differences in bacteraemia between the two strains were not statistically significant. We also measured levels of interleukin-6 (IL-6) in plasma from blood collected at 48 h. SR-A-/- animals consistently showed significantly higher levels of the pro-inflammatory cytokine IL-6 than wild-type animals.
###end p 64
###begin p 65
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g004">Figure 4</xref>
Spleen sections were also analysed by immunohistochemistry with three antibodies, FA-11 (an intracellular macrophage marker, staining macrosialin [CD68]), 7/4 Ag (a neutrophil and monocyte marker) and MHC-II (an antibody recognising the major histocompatibility class II molecule, a marker expressed on resident dendritic cells and activated macrophages). FA-11 (macrosialin) is a pan-macrophage marker, indicating the macrophage infiltration into the spleen. Staining with MHC-II shows that the macrophages are activated. The 7/4 Ag staining shows the infiltration of activated monocytes and polymorphonuclear neutrophils (Figure 4). Therefore all the splenic samples showed a high number of infiltrating activated macrophages and neutrophils.
###end p 65
###begin title 66
Intact spleen segments from infected animals were fixed in paraformaldehyde, embedded in OCT, sectioned, and stained with various antibodies for the infiltration of macrophages (FA-11), polymorphonuclear neutrophils, and activated monocytes (7/4Ag) and activated macrophages (MHC-II), as described in the text.
###end title 66
###begin p 67
All data are representative of at least three individual experiments.
###end p 67
###begin title 68
###xml 10 25 10 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
###xml 10 25 <span type="species:ncbi:487">N. meningitidis</span>
Effect of N. meningitidis Mutants In Vivo
###end title 68
###begin p 69
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 286 301 286 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 455 471 455 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g005">Figure 5A and 5B</xref>
###xml 587 590 587 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 796 812 796 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g005">Figure 5A and 5B</xref>
###xml 959 962 959 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 972 981 972 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g005">Figure 5C</xref>
###xml 1074 1077 1074 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1159 1168 1159 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000297-g005">Figure 5D</xref>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 320 325 <span type="species:ncbi:10090">mouse</span>
###xml 336 341 <span type="species:ncbi:9606">human</span>
###xml 664 669 <span type="species:ncbi:10090">mouse</span>
###xml 1221 1225 <span type="species:ncbi:10090">mice</span>
Next, we tested the mutant bacteria lacking both SR-A ligands, NMB0278 and NMB1220, for their ability to establish septicaemia in wild-type and SR-A-/- animals. Groups of eleven age-matched female C57BL/6J wild-type and corresponding SR-A-/- knock-out mice were injected i.p. with 1x105N. meningitidis MC58-278-1220 cfu/mouse and 10 mg human holo-transferrin as before. Animals were monitored regularly, assigned health scores and their survival plotted (Figure 5A and 5B). Animals in both groups exhibited symptoms of septicaemia, however differences observed between wild-type and SR-A-/- animals when infected with wild-type bacteria, were absent. Overall both mouse strains showed fewer symptoms of septicaemia and had a higher survival rate when infected with mutant MC58-278-1220 bacteria (Figure 5A and 5B). No statistically significant differences were observed in the levels of bacteraemia in either the blood or the spleen between wild-type and SR-A-/- animals (Figure 5C). IL-6 levels were also not statistically significantly different between wild-type and SR-A-/- animals and were lower overall than in animals infected with wild-type bacteria (Figure 5D). Therefore the SR-A-mediated effects observed when mice were infected with wild-type bacteria were abrogated for mutant bacteria lacking two SR-A ligands.
###end p 69
###begin title 70
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 119 134 119 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
Eleven 6-8-week-old female C57BL/6J wild-type and corresponding SR-A-/- mice were infected intraperitoneally with 1x105N. meningitidis MC58-278-1220 and 10 mg human holo-transferrin per mouse.
###end title 70
###begin p 71
###xml 46 51 <span type="species:ncbi:9606">human</span>
At 18 h post-injection a second dose of 10 mg human holo-transferrin was administered i.p. (A) The health of the animals was monitored regularly and scored at each time point according to the symptoms presented as before. Scores were then collated for each group at each time point, averaged, and plotted. (B) The survival of each group was plotted and the statistical curve comparison was determined using the Log-rank (Mantel Cox) test. (C) Blood was collected by tail vein bleed at 20 h, and at termination (48 h) blood was collected by cardiac puncture and spleens were collected and homogenised. Serial dilutions of blood and spleen were plated on bacterial growth medium, incubated, and bacterial colonies were counted. Counts for 11 individual animals in each group are plotted. Results were analysed using a two-tailed, unpaired t test (P>0.05). (D) The concentration of interleukin-6 in the plasma was measured at termination (48 h) using a standard ELISA assay. Individual measurements from 11 animals in each group are plotted. Results were analysed using a two-tailed, unpaired t test (P>0.05). All data are representative of at least three individual experiments.
###end p 71
###begin title 72
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
In Vivo Competition Assay
###end title 72
###begin p 73
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 526 527 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000297-t004">Table 4</xref>
###xml 953 956 953 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1185 1188 1185 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
When MC58-278-1220 mutant bacteria were injected into wild-type and SR-A-/- mice, we observed not only the abrogation of the SR-A-mediated effect, but also that mutant bacteria seemed to cause less severe symptoms of septicaemia and animals had a higher survival rate. To test whether this was a bona fide observation, we employed a competition assay to determine whether wild-type bacteria would out-compete mutant bacteria in vivo. To obtain a bacterial count for wild-type and mutant bacteria in each case, we injected 1x106 wild-type MC58 and mutant MC58-278-1220 bacteria i.p. at a ratio of 1:1. The respective bacterial numbers in blood and spleen were determined by replicate plating of serial dilutions on BHI medium and BHI medium supplemented with kanamycin, which would select for mutant bacteria carrying the kanamycin resistance cassette used to disrupt the gene encoding NMB0278. Table 4 shows the competitive indices in wild-type and SR-A-/- animals. A competitive index of 6.891 and 5.090 was obtained for bacterial counts from blood and spleen from wild-type animals, respectively. This indicates that more wild-type bacteria remained than did mutant bacteria. In SR-A-/- animals, a competitive index of 2.781 and 1.660 was obtained from blood and spleen, respectively.
###end p 73
###begin title 74
###xml 31 46 31 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 66 81 66 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 31 46 <span type="species:ncbi:487">N. meningitidis</span>
###xml 66 81 <span type="species:ncbi:487">N. meningitidis</span>
Competitive Index of wild-type N. meningitidis MC58 versus mutant N. meningitidis-278-1220.
###end title 74
###begin p 75
(wild-type output/mutant output)/(wild-type input/mutant input).
###end p 75
###begin p 76
Paired t test.
###end p 76
###begin p 77
Values marked with an asterisk are statistically significant with a 95% confidence interval.
###end p 77
###begin title 78
Discussion
###end title 78
###begin p 79
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 92 107 92 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 160 175 160 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Peiser3">[18]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Pizza1">[32]</xref>
###xml 659 666 659 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Sinha1">[33]</xref>
###xml 759 781 759 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenzae</italic>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Rosadini1">[34]</xref>
###xml 968 975 968 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1036 1040 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Hale1">[35]</xref>
###xml 1253 1268 1253 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 92 107 <span type="species:ncbi:487">N. meningitidis</span>
###xml 160 175 <span type="species:ncbi:487">N. meningitidis</span>
###xml 659 666 <span type="species:ncbi:562">E. coli</span>
###xml 759 781 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 800 805 <span type="species:ncbi:9606">human</span>
###xml 968 975 <span type="species:ncbi:562">E. coli</span>
###xml 1253 1268 <span type="species:ncbi:487">N. meningitidis</span>
In this study we evaluated the in vivo role of SR-A in meningococcal septicaemia induced by N. meningitidis MC58 (serogroup B), and ascertained the role of the N. meningitidis surface proteins, previously identified to be ligands for SR-A [18]. The neisserial surface protein ligands were NMB0278, NMB0667 and NMB1220. NMB1220 has been shown to be surface expressed and similar experiments showed the surface expression of NMB0278 and NMB0667 [32] and personal communication). The function of these proteins is unknown, however they show some homology to proteins identified in other bacterial species. Sequence analysis suggests that NMB0278 has homology to E. coli DsbA, which functions in disulphide bond formation [33]. Interestingly, the DsbA protein of Haemophilus influenzae, another obligate human pathogen colonising the nasopharynx, has recently been shown to be a virulence factor [34]. The C-terminus of NMB0667 has 20% homology with the ZipA protein from E. coli, which is involved in septum formation during cell division [35]. NMB1220 belongs to the stomatin/Mec-2 protein family, which are oligomeric lipid raft-associated integral proteins that regulate the function of ion channels and transporters. We constructed deletion mutants in N. meningitidis MC58 for all three proteins, respectively, and also generated a double mutant lacking NMB0278 and NMB1220. We employed several approaches to delete NMB0667, however this mutation proved lethal, which may be linked to the possible role of NMB0667 in septum formation during cell division. All the mutant strains showed no deficiency in growth characteristics or LPS and protein profile. Through PCR analysis, we showed that the genes encoding these proteins are present in a wide variety of neisserial strains, including invasive disease and carriage strains. Closely related homologues are also present in other bacteria, making them ideal PAMPs (pathogen-associated molecular patterns) and targets for PRRs. It should however be noted that since the genes encoding these proteins are also present in non-pathogenic bacteria and commensal strains, the term "PAMPs", though commonly used in this context, could be considered a misnomer.
###end p 79
###begin p 80
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 458 473 458 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</italic>
###xml 525 528 525 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;<italic>/</italic>&#8722;</sup>
###xml 679 682 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 899 902 899 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1067 1071 1067 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000297-Prins1">[36]</xref>
###xml 1170 1173 1170 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1351 1366 1351 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 1405 1412 1405 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 402 408 <span type="species:ncbi:10090">murine</span>
###xml 458 473 <span type="species:ncbi:487">N. meningitidis</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 1060 1066 <span type="species:ncbi:9606">humans</span>
###xml 1351 1366 <span type="species:ncbi:487">N. meningitidis</span>
In vitro uptake of the mutant bacteria by bone marrow-derived macrophages from wild-type and SR-A-/- animals did not show any differences when compared to wild-type bacteria. This could be attributed to the fact that at least one other SR-A ligand, NMB0667, was present, along with two NMB0278 homologues, which could mediate recognition and uptake. Therefore, we studied the in vivo role of SR-A in a murine model for meningococcal septicaemia. We injected N. meningitidis MC58 into wild-type C57BL/6J and corresponding SR-A-/- mice and monitored the manifestation of symptoms of septicaemia (ruffled fur, sticky eyes), as well as the survival of the animals. The health of SR-A-/- animals consistently deteriorated more rapidly and there was a 33% difference in survival when compared to wild-type animals. Analysis of blood samples taken at 20 h post-infection and at termination showed that SR-A-/- animals had higher levels of bacteraemia and the pro-inflammatory cytokine, IL-6. Induction of IL-6 is commonly associated with meningococcal septicaemia in humans [36]. Although not statistically significant, spleen samples also indicated higher bacteraemia for SR-A-/- animals, and splenic sections revealed infiltration of activated macrophages, monocytes and neutrophils. Therefore, in this model, SR-A played an important role in clearance of N. meningitidis MC58. This is the first report of the in vivo importance of SR-A in a model using a Gram-negative pathogenic organism.
###end p 80
###begin p 81
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1245 1260 1245 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N. meningitidis</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 1245 1260 <span type="species:ncbi:487">N. meningitidis</span>
Subsequently, we injected the mutant bacteria lacking both NMB0278 and NMB1220 at the same dose i.p. into wild-type and SR-A-/- mice and monitored them as before. Interestingly, the differences observed between the mouse strains when infecting with wild-type bacteria were abrogated for mutant bacteria lacking the two SR-A ligands, and overall less severe symptoms were observed. Furthermore, the levels of bacteraemia and IL-6 between wild-type and SR-A-/- animals did not differ significantly. Therefore the surface proteins NMB0278 and NMB1220 are at least partially implicated in the SR-A-mediated effects observed for wild-type bacteria. We previously showed that NMB0278 and NMB1220 are also Toll-like receptor (TLR) agonists, and that SR-A was required for full activation of TLR pathways (Pluddemann et al. JII, in press). Although SR-A ligation does not directly mediate cytokine induction, the overall lower cytokine levels in animals infected with mutant bacteria could be linked to the absence of NMB0278 and NMB1220. The competitive index assay confirmed that mutant bacteria were cleared more readily, proving that this observation was not due to inter-experimental variations. These data indicate a role for SR-A in clearance of N. meningitidis and development of symptoms of septicaemia. Thus far, the development and progression of septicaemia has mainly been linked to LPS, however these data indicate an additional role of neisserial surface protein recognition in this process.
###end p 81
###begin p 82
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
It is clear that the i.p. mouse challenge model described here does not represent the natural pathogenesis of neisserial disease, however it does model the overwhelming septicaemia that is characteristic of invasive meningococcal disease. Since SR-A is not expressed on polymorphonuclear neutrophils, our results signify an important role for macrophages and SR-A in the development and progression of meningococcal septicaemia.
###end p 82
###begin p 83
The authors would like to thank S. Mukhopadhyay and R. Stillion for their advice and expertise, as well as technical support staff for their invaluable assistance. We would also like to thank A. Gorringe and colleagues (HPA, Porton Down, UK) for their advice in setting up the animal model. The authors would also like to thank M. Pizza and S. Savino (Novartis Vaccines and Diagnostics Srl, Siena, Italy) for their contributions and advice.
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
The interaction of macrophage receptors with bacterial ligands.
###end article-title 85
###begin article-title 86
Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).
###end article-title 86
###begin article-title 87
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs.
###end article-title 87
###begin article-title 88
Silica-directed mast cell activation is enhanced by scavenger receptors.
###end article-title 88
###begin article-title 89
###xml 86 92 <span type="species:ncbi:10090">murine</span>
Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response.
###end article-title 89
###begin article-title 90
###xml 35 40 <span type="species:ncbi:9606">human</span>
Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions.
###end article-title 90
###begin article-title 91
###xml 63 79 <span type="species:ncbi:562">Escherichia coli</span>
Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro.
###end article-title 91
###begin article-title 92
Recognition and plasma clearance of endotoxin by scavenger receptors.
###end article-title 92
###begin article-title 93
Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor.
###end article-title 93
###begin article-title 94
The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides.
###end article-title 94
###begin article-title 95
The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid.
###end article-title 95
###begin article-title 96
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection.
###end article-title 96
###begin article-title 97
Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis.
###end article-title 97
###begin article-title 98
The Macrophage Scavenger Receptor SR-AI/II and lung defense against pneumococci and particles.
###end article-title 98
###begin article-title 99
The macrophage Scavenger Receptor Type A is expressed by activated macrophages and protects the host against lethal endotoxic shock.
###end article-title 99
###begin article-title 100
The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis.
###end article-title 100
###begin article-title 101
###xml 86 108 <span type="species:ncbi:487">Neisseria meningitidis</span>
The Class A Macrophage Scavenger Receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.
###end article-title 101
###begin article-title 102
###xml 18 40 <span type="species:ncbi:487">Neisseria meningitidis</span>
Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay.
###end article-title 102
###begin article-title 103
Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4.
###end article-title 103
###begin article-title 104
###xml 78 100 <span type="species:ncbi:487">Neisseria meningitidis</span>
Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant.
###end article-title 104
###begin article-title 105
###xml 15 36 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
The surface of Neisseria gonorrhoeae: isolation of the major components of the outer membrane.
###end article-title 105
###begin article-title 106
Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
###end article-title 106
###begin article-title 107
###xml 94 116 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 121 143 <span type="species:ncbi:727">Haemophilus influenzae</span>
lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae.
###end article-title 107
###begin article-title 108
###xml 51 73 <span type="species:ncbi:487">Neisseria meningitidis</span>
Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis.
###end article-title 108
###begin article-title 109
###xml 41 63 <span type="species:ncbi:727">Haemophilus influenzae</span>
Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization.
###end article-title 109
###begin article-title 110
Animal models for meningococcal disease.
###end article-title 110
###begin article-title 111
###xml 43 65 <span type="species:ncbi:487">Neisseria meningitidis</span>
Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity.
###end article-title 111
###begin article-title 112
###xml 15 37 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin.
###end article-title 112
###begin article-title 113
###xml 115 137 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Mechanism of impaired iron release by the reticuloendothelial system during the hypoferremic phase of experimental Neisseria meningitidis infection in mice.
###end article-title 113
###begin article-title 114
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
###end article-title 114
###begin article-title 115
###xml 59 81 <span type="species:ncbi:487">Neisseria meningitidis</span>
Functional diversity of three different DsbA proteins from Neisseria meningitidis.
###end article-title 115
###begin article-title 116
###xml 61 83 <span type="species:ncbi:727">Haemophilus influenzae</span>
The periplasmic disulfide oxidoreductase DsbA contributes to Haemophilus influenzae pathogenesis.
###end article-title 116
###begin article-title 117
###xml 115 122 <span type="species:ncbi:562">E. coli</span>
Direct binding of FtsZ to ZipA, an essential component of the septal ring structure that mediates cell division in E. coli.
###end article-title 117
###begin article-title 118
Endotoxin release and cytokine production in acute and chronic meningococcaemia.
###end article-title 118
###begin article-title 119
Point mutation in meningococcal por A gene associated with increased endemic disease.
###end article-title 119
###begin article-title 120
Carried meningococci in the Czech Republic: a diverse recombining population.
###end article-title 120
###begin article-title 121
###xml 115 137 <span type="species:ncbi:487">Neisseria meningitidis</span>
Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.
###end article-title 121
###begin article-title 122
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.
###end article-title 122
###begin p 123
The authors have declared that no competing interests exist.
###end p 123
###begin p 124
Work in the laboratory of SG is funded by the MRC, United Kingdom. Work in the laboratory of ERM is funded by the MRC, United Kingdom, and by the Wellcome Trust. JCH is funded by the NIHR Biomedical Research Centre Programme.
###end p 124

